Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress

Abstract

Cells are constantly subjected to various types of endogenous and exogenous stressful stimuli, which can cause serious and even permanent damage. The ability of a cell to sense and adapt to environmental alterations is thus vital to maintain tissue homeostasis during development and adult life. Here, we review some of the major phenotypic characteristics of the hostile tumour microenvironment and the emerging roles of extracellular vesicles in these events.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 110

1. 1.

   Kültz D. Molecular and evolutionary basis of the cellular stress response. Ann Rev Physiol. 2005;67:225-57.

   Not in our library10.1146/annurev.physiol.67.040403.103635

2. 2.
   Cellular Stress Responses: Cell Survival and Cell Death · 2010

   No notice
3. 3.

   Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res. 2011;1:98-110.

   Not in our library

4. 4.

   De Maio A. Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. Cell Stress Chaperones. 2011;16:235-49.

   Not in our library10.1007/s12192-010-0236-4

5. 5.

   Policastro LL, Ibañez IL, Notcovich C, Duran HA, Podhajcer OL. The tumor microenvironment: characterization, redox considerations, and novel approaches for reactive Oxygen species-targeted gene therapy. Antioxid Redox Signal.

   Not in our library10.1089/ars.2011.4367

6. 6.

   Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 1989;8:98-101.

   Not in our library

7. 7.

   Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011;17:1359-70.

   Not in our library10.1038/nm.2537

8. 8.

   Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392-401.

   Not in our library10.1038/nrc1877

9. 9.

   de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6:24-37.

   Not in our library10.1038/nrc1782

10. 10.

    Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395-406.

    Not in our library10.1083/jcb.201102147

11. 11.

    Lorger M. Tumor microenvironment in the brain. Cancers. 2012;4:218-43.

    Not in our library10.3390/cancers4010218

12. 12.

    Gillies RJ, Verduzco D, Gatenby RA. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer. 2012;12:487-93.

    Not in our library10.1038/nrc3298

13. 13.

    Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11:393-410.

    Not in our library10.1038/nrc3064

14. 14.

    Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer. 2008;8:967-75.

    Not in our library10.1038/nrc2540

15. 15.

    Chiche J, Brahimi-Horn MC, Pouysségur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med. 2010;14:771-94.

    Not in our library10.1111/j.1582-4934.2009.00994.x

16. 16.

    McCarty MF, Whitaker J. Manipulating tumor acidification as a cancer treatment strategy. Altern Med Rev. 2010;15:264-72.

    Not in our library

17. 17.

    Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science. 2009;325:1555-9.

    Not in our library10.1126/science.1174229

18. 18.
    Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison · 2012

    No notice
19. 19.

    Shieh AC. Biomechanical forces shape the tumor microenvironment. Ann Biomed Eng. 2011;39:1379-89.

    Not in our library10.1007/s10439-011-0252-2

20. 20.

    Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29:235-71.

    Not in our library10.1146/annurev-immunol-031210-101324

21. 21.

    Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6:715-27.

    Not in our library10.1038/nri1936

22. 22.

    Wind NS, Holen I. Multidrug resistance in breast cancer: from in vitro models to clinical studies. Int J Breast Cancer. 2011;2011:967419.

    Not in our library10.4061/2011/967419

23. 23.
    Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death · 2012

    No notice
24. 24.

    Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012;72:4875-82.

    Not in our library10.1158/0008-5472.can-12-2217

25. 25.

    D'Asti E, Garnier D, Lee TH, Montermini L, Meehan B, Rak J. Oncogenic extracellular vesicles in brain tumor progression. Front Physiol. 2012;3:294.

    Not in our library10.3389/fphys.2012.00294

26. 26.

    van Doormaal FF, Kleinjan A, Di Nisio M, Büller HR, Nieuwland R. Cell-derived microvesicles and cancer. Neth J Med. 2009;67:266-73.

    Not in our library

27. 27.

    Friend C, Marovitz W, Henie G, Henie W, Tsuei D, Hirschhorn K. Observations on cell lines derived from a patient with Hodgkin's disease. Cancer Res. 1978;38:2581-91.

    Not in our library

28. 28.

    Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J, et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother. 2010;59:841-50.

    Not in our library10.1007/s00262-009-0808-2

29. 29.

    Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110:13-21.

    Not in our library10.1016/j.ygyno.2008.04.033

30. 30.

    Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94:3791-99.

    Not in our library

31. 31.

    Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161-72.

    Not in our library10.1084/jem.183.3.1161

32. 32.

    Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581-93.

    Not in our library10.1038/nri2567

33. 33.

    Savina A, Fader CM, Damiani MT, Colombo MI. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic. 2005;6:131-43.

    Not in our library10.1111/j.1600-0854.2004.00257.x

34. 34.

    Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12:19-30.

    Not in our library10.1038/ncb2000

35. 35.

    Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, Lauterbach MA, et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol. 2010;189:223-32.

    Not in our library10.1083/jcb.200911018

36. 36.

    Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006;66:4795-801.

    Not in our library10.1158/0008-5472.can-05-4579

37. 37.

    Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319:1244-7.

    Not in our library10.1126/science.1153124

38. 38.

    Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14:677-85.

    Not in our library10.1038/ncb2502

39. 39.

    Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol. 2006;172:923-35.

    Not in our library10.1083/jcb.200508014

40. 40.

    Lenassi M, Cagney G, Liao M, Vaupotic T, Bartholomeeusen K, Cheng Y, et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic. 2010;11:110-22.

    Not in our library10.1111/j.1600-0854.2009.01006.x

41. 41.
    Higher-Order Oligomerization Targets Plasma Membrane Proteins and HIV Gag to Exosomes · 2007

    No notice
42. 42.

    Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009;19:1875-85.

    Not in our library10.1016/j.cub.2009.09.059

43. 43.

    Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun. 2011;2:180.

    Not in our library10.1038/ncomms1180

44. 44.

    Guescini M, Genedani S, Stocchi V, Agnati LF. Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J Neural Transm. 2010;117:1-4.

    Not in our library10.1007/s00702-009-0288-8

45. 45.

    Guescini M, Guidolin D, Vallorani L, Casadei L, Gioacchini AM, Tibollo P, et al. C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp Cell Res. 2010;316:1977-84.

    Not in our library10.1016/j.yexcr.2010.04.006

46. 46.

    Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 2002;360:295-305.

    Not in our library10.1016/s0140-6736(02)09552-1

47. 47.

    Svensson KJ, Kucharzewska P, Christianson HC, Sköld S, Löfstedt T, Johansson MC, et al. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci U S A. 2011;108:13147-52.

    Not in our library10.1073/pnas.1104261108

48. 48.

    Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 2011;71:5346-56.

    Not in our library10.1158/0008-5472.can-11-0241

49. 49.

    Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008;10:619-24.

    Not in our library10.1038/ncb1725

50. 50.

    Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A. 2009;106:3794-99.

    Not in our library10.1073/pnas.0804543106

51. 51.

    Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470-6.

    Not in our library10.1038/ncb1800

52. 52.

    Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, et al. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia. 2006;8:96-103.

    Not in our library10.1593/neo.05583

53. 53.

    Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, Papworth GD, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004;104:3257-66.

    Not in our library10.1182/blood-2004-03-0824

54. 54.

    Segura E, Guérin C, Hogg N, Amigorena S, Théry C. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol. 2007;179:1489-96.

    Not in our library10.4049/jimmunol.179.3.1489

55. 55.

    Véron P, Segura E, Sugano G, Amigorena S, Théry C. Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells. Blood Cells Mol Dis. 2005;35:81-8.

    Not in our library10.1016/j.bcmd.2005.05.001

56. 56.

    Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J. 2004;18:977-9.

    Not in our library10.1096/fj.03-1094fje

57. 57.

    Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18:883-91.

    Not in our library10.1038/nm.2753

58. 58.

    Wysoczynski M, Ratajczak MZ. Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors. Int J Cancer. 2009;125:1595-603.

    Not in our library10.1002/ijc.24479

59. 59.

    Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, Xie LX, et al. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev. 2012;21:3289-97.

    Not in our library10.1089/scd.2012.0095

60. 60.
    Hypoxic enhancement of exosome release by breast cancer cells · 2012

    No notice
61. 61.

    Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284:34211-22.

    Not in our library10.1074/jbc.m109.041152

62. 62.
    Exosomes Communicate Protective Messages during Oxidative Stress; Possible Role of Exosomal Shuttle RNA · 2010

    No notice
63. 63.
    Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B Cells · 2011

    No notice
64. 64.

    Zhan R, Leng X, Liu X, Wang X, Gong J, Yan L, et al. Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway involving exosomes. Biochem Biophys Res Commun. 2009;387:229-33.

    Not in our library10.1016/j.bbrc.2009.06.095

65. 65.

    Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. Induction of heat shock proteins in B-cell exosomes. J Cell Sci. 2005;118:3631-8.

    Not in our library10.1242/jcs.02494

66. 66.

    Chen T, Guo J, Yang M, Zhu X, Cao X. Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol. 2011;186:2219-28.

    Not in our library10.4049/jimmunol.1002991

67. 67.

    Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 1996;88:3456-64.

    Not in our library

68. 68.

    Lv LH, Wan YL, Lin Y, Zhang W, Yang M, Li GL, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem. 2012;287:15874-85.

    Not in our library10.1074/jbc.m112.340588

69. 69.

    Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine JC, et al. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ. 2008;15:1723-33.

    Not in our library10.1038/cdd.2008.104

70. 70.

    Nikolova-Karakashian MN, Rozenova KA. Ceramide in stress response. Adv Exp Med Biol. 2010;688:86-108.

    Not in our library10.1007/978-1-4419-6741-1_6

71. 71.

    Sawada M, Nakashima S, Kiyono T, Nakagawa M, Yamada J, Yamakawa H, et al. p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells. Oncogene. 2001;20:1368-78.

    Not in our library10.1038/sj.onc.1204207

72. 72.

    Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood. 2005;105:1734-41.

    Not in our library10.1182/blood-2004-05-2042

73. 73.

    Di Vizio D, Kim J, Hager MH, Morello M, Yang W, Lafargue CJ, et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 2009;69:5601-9.

    Not in our library10.1158/0008-5472.can-08-3860

74. 74.

    Wang Y, Roche O, Xu C, Moriyama EH, Heir P, Chung J, et al. Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci U S A. 2012;109:4892-7.

    Not in our library10.1073/pnas.1112129109

75. 75.

    MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity. 2001;15:825-35.

    Not in our library10.1016/s1074-7613(01)00229-1

76. 76.

    Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, et al. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res. 2003;63:5573-81.

    Not in our library

77. 77.

    Giusti I, D'Ascenzo S, Millimaggi D, Taraboletti G, Carta G, Franceschini N, et al. Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia. 2008;10:481-8.

    Not in our library10.1593/neo.08178

78. 78.

    Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, et al. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 2009;23:1541-57.

    Not in our library10.1096/fj.08-122184

79. 79.
    Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells · 2012

    No notice
80. 80.

    Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-9.

    Not in our library10.1038/ncb1596

81. 81.

    Carayon K, Chaoui K, Ronzier E, Lazar I, Bertrand-Michel J, Roques V, et al. Proteolipidic composition of exosomes changes during reticulocyte maturation. J Biol Chem. 2011;286:34426-39.

    Not in our library10.1074/jbc.m111.257444

82. 82.

    Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, et al. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci U S A. 2011;108:15336-41.

    Not in our library10.1073/pnas.1102855108

83. 83.

    Khan S, Jutzy JM, Aspe JR, McGregor DW, Neidigh JW, Wall NR. Survivin is released from cancer cells via exosomes. Apoptosis. 2011;16:1-12.

    Not in our library10.1007/s10495-010-0534-4

84. 84.

    Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics. 2010;9:1085-99.

    Not in our library10.1074/mcp.m900381-mcp200

85. 85.

    Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14:249-56.

    Not in our library10.1038/ncb2441

86. 86.
    Cellular stress conditions are reflected in the protein and RNA content of endothelial cell‐derived exosomes · 2012

    No notice
87. 87.
    High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients · 2009

    No notice
88. 88.

    Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS, et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med. 2012;18:1835-40.

    Not in our library10.1038/nm.2994

89. 89.
    Changes in circulating microRNA levels associated with prostate cancer · 2012

    No notice
90. 90.

    Yokota N, Koizume S, Miyagi E, Hirahara F, Nakamura Y, Kikuchi K, et al. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer. 2009;101:2023-9.

    Not in our library10.1038/sj.bjc.6605406

91. 91.

    van den Berg YW, Osanto S, Reitsma PH, Versteeg HH. The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood. 2012;119:924-32.

    Not in our library10.1182/blood-2011-06-317685

92. 92.

    McCormick R, Buffa FM, Ragoussis J, Harris AL. The role of hypoxia regulated microRNAs in cancer. Curr Top Microbiol Immunol. 2010;345:47-70.

    Not in our library10.1007/82_2010_76

93. 93.

    Wang H, Wang ZH, Kong J, Yang MY, Jiang GH, Wang XP, et al. Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress. Mol Med. 2012;18:159-66.

    Not in our library10.2119/molmed.2011.00295

94. 94.

    Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature. 2011;475:226-30.

    Not in our library10.1038/nature10169

95. 95.

    Whitlow MB, Klein LM. Response of SCC-12F, a human squamous cell carcinoma cell line, to complement attack. J Invest Dermatol. 1997;109:39-45.

    Not in our library10.1111/1523-1747.ep12276459

96. 96.

    Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med. 2002;195:1303-16.

    Not in our library10.1084/jem.20011624

97. 97.

    Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL, et al. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis. 2005;35:169-73.

    Not in our library10.1016/j.bcmd.2005.07.001

98. 98.

    Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 2007;67:7458-66.

    Not in our library10.1158/0008-5472.can-06-3456

99. 99.
    Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg) · 2010

    No notice
100. 100.

     Clayton A, Tabi Z. Exosomes and the MICA-NKG2D system in cancer. Blood Cells Mol Dis. 2005;34:206-13.

     Not in our library10.1016/j.bcmd.2005.03.003

101. 101.

     Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 2006;66:9290-8.

     Not in our library10.1158/0008-5472.can-06-1819

102. 102.

     Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 2010;120:457-71.

     Not in our library10.1172/jci40483

103. 103.

     Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 2005;113:752-60.

     Not in our library10.1002/ijc.20657

104. 104.

     Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 2003;63:4331-7.

     Not in our library

105. 105.

     Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W, et al. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther. 2005;4:1595-604.

     Not in our library10.1158/1535-7163.mct-05-0102

106. 106.

     Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol. 2012;227:658-67.

     Not in our library10.1002/jcp.22773

107. 107.

     Rzeszowska-Wolny J, Przybyszewski WM, Widel M. Ionizing radiation-induced bystander effects, potential targets for modulation of radiotherapy. Eur J Pharmacol. 2009;625:156-64.

     Not in our library10.1016/j.ejphar.2009.07.028

108. 108.

     Matsumoto H, Hayashi S, Hatashita M, Ohnishi K, Shioura H, Ohtsubo T, et al. Induction of radioresistance by a nitric oxide-mediated bystander effect. Radiat Res. 2001;155:387-96.

     Not in our library10.1667/0033-7587(2001)155[0387:iorban]2.0.co;2

109. 109.

     Dickey JS, Baird BJ, Redon CE, Sokolov MV, Sedelnikova OA, Bonner WM. Intercellular communication of cellular stress monitored by gamma-H2AX induction. Carcinogenesis. 2009;30:1686-95.

     Not in our library10.1093/carcin/bgp192

110. 110.

     Hei TK, Zhou H, Chai Y, Ponnaiya B, Ivanov VN. Radiation induced non-targeted response: mechanism and potential clinical implications. Curr Mol Pharmacol. 2011;4:96-105.

     Not in our library10.2174/1874467211104020096

Cited by papers we hold 10

• Scalable Production of Extracellular Vesicles and Its Therapeutic Values: A Review · 2022
  No notice
• Exosomes and Their Noncoding RNA Cargo Are Emerging as New Modulators for Diabetes Mellitus · 2019
  No notice
• Mechanisms associated with biogenesis of exosomes in cancer · 2019
  No notice
• Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases · 2018
  No notice
• Role of exosomal proteins in cancer diagnosis · 2017
  No notice
• MicroRNA in Glioblastoma: An Overview · 2017
  No notice
• Exosomes in Cancer Diagnostics · 2017
  No notice
• Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer · 2015
  No notice
• Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia · 2014
  No notice
• Exosome in Tumour Microenvironment: Overview of the Crosstalk between Normal and Cancer Cells · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.